HK2 and malignant peripheral nerve sheath tumor: These results set the stage for HK2 targeting in MPNST, but the use of pharmacological HK2 inhibitors has proven arduous, as side effects on other HK isozymes lead to systemic dysregulation of glucose metabolism and toxicity [15].